NASDAQ · Medical - Devices

VMD (VMD) Stock

$12.12 +2.97% NASDAQ: VMD Healthcare

Valuation

MetricValue
Price$12.12
Market Cap$464.64M
P/E Ratio26.16
P/B Ratio2.61
P/S Ratio1.29
EPS (TTM)$0.37
52-Week High$12.60
52-Week Low$5.93
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE10.56%
ROA6.98%
ROCE14.58%
Gross Margin7.41%
Operating Margin7.78%
Net Margin5.20%
Debt/Equity0.09
Current Ratio1.17

Annual Financials (USD)

Metric20212022202320242025
Revenue$117.0M$139.0M$183.0M$224.0M$270.0M
Operating Profit$12.0M$8.0M$14.0M$18.0M$21.0M
Net Profit$9.0M$6.0M$10.0M$11.0M$15.0M
EPS$0.22$0.15$0.25$0.28$0.37
Op Margin9.9%5.9%7.8%8.0%7.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$118.0M$117.0M$155.0M$177.0M$215.0M
Total Liabilities$23.0M$20.0M$41.0M$44.0M$71.0M
Cash$28.0M$17.0M$13.0M$18.0M$14.0M
Borrowings$7.0M$1.0M$10.0M$7.0M$16.0M

Latest News

Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details ACCESS Newswire · Jul 21, 2026 Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026? Motley Fool · Jun 10, 2026 US Undiscovered Gems To Watch In May 2026 Simply Wall St. · May 29, 2026 Top Growth Companies With Significant Insider Ownership May 2026 Simply Wall St. · May 27, 2026 Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26 TMX Newsfile · May 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$22.0M$28.0M$45.0M$39.0M$52.0M
Investing Cash Flow$-39.0M$-47.0M$-78.0M$-68.0M$-90.0M
Financing Cash Flow$-1.0M$-9.0M$1.0M$0$-15.0M
Net Cash Flow$-3.0M$-11.0M$-4.0M$5.0M$-4.0M
Free Cash Flow$3.0M$5.0M$19.0M$1.0M$12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA7.46
FCF Yield7.02%
Quick Ratio1.10
Interest Coverage21.00
Return 1Y80.65%
Return 3Y30.39%
Return 5Y76.37%

Ownership

Insiders Held13.67%
Institutions Held69.00%
Institutions Float Held79.93%
Institutional HolderSharesReport Date
Blackrock Inc.4,622,5622026-03-31
Forager Capital Management, LLC2,825,8712026-03-31
Goldman Sachs Group Inc1,421,6342026-03-31
Vanguard Capital Management LLC1,303,3842026-03-31
Ameriprise Financial, Inc.898,3192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About VMD

VMD is led by CEO Casey Hoyt, employs 1,222 people, headquartered in US, publicly traded since 2019.

VMD stock trades at $12.12 with a market capitalization of $464.64M. The stock is valued at a price-to-earnings (P/E) ratio of 26.16, price-to-book of 2.61, price-to-sales of 1.29. Over the past 52 weeks the stock has ranged between $5.93 and $12.60, and currently trades 3.8% below its 52-week high.

On profitability, VMD generates a return on equity (ROE) of 10.56%, return on capital employed of 14.58%, an operating margin of 7.78%, a net profit margin of 5.20%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides